Articles

Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT

Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv University, Israel
Vanderbilt University Medical Center, Nashville, TN, USA
Acute Leukemia Working Party–EBMT and Department of Hematology and Cell Therapy, Hȏpital Saint-Antoine, Paris, France;INSERM UMR 938, Paris, France;Université Pierre et Marie Curie, Paris, France
Peking University People’s Hospital, Institute of Haematology, Xicheng District, Beijing, China
Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy
Tor Vergata University of Rome, Stem Cell Transplant Unit, Policlinico Universitario Tor Vergata, Italy
Klinikum Grosshadern, Med. Klinik III, Munich, Germany
Medical Park Hospitals, Stem Cell Transplant Unit, Antalya, Turkey
S.S.C.V.D Trapianto di Cellule Staminali A.O.U Citta della Salute e della Scienza di Torino, Italy
Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey
Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, France
University Hospital Gasthuisberg, Department of Hematology, Leuven, Belgium
Universitaetsklinikum Dresden Medizinische Klinik und Poliklinik I, Germany
Acute Leukemia Working Party–EBMT and Department of Hematology and Cell Therapy, Hȏpital Saint-Antoine, Paris, France;INSERM UMR 938, Paris, France;Université Pierre et Marie Curie, Paris, France
Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv University, Israel;Acute Leukemia Working Party–EBMT and Department of Hematology and Cell Therapy, Hȏpital Saint-Antoine, Paris, France;Université Pierre et Marie Curie, Paris, France
Vol. 102 No. 6 (2017): June, 2017 https://doi.org/10.3324/haematol.2016.160804